Profile
Sector:
HealthcareIndustry:
Medical Instruments & SuppliesCountry:
United StatesIPO:
18 June 2021Website:
http://www.femasys.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 05 Jul 2024 22:32:42 GMTDividend
Analysts recommendations
Institutional Ownership
FEMY Latest News
Lee-Sepsick talked about the FemCerv® Endocervical Tissue Sampler from the company and how it is used in diagnosing cervical cancer.
Femasys (FEMY) lacks the necessary elements for a potential earnings surprise in its upcoming report. Be ready with the main expectations.
Underlying prices exhibited a notable cooling trend, providing the Federal Reserve shows evidence of softer inflation. While Americans did indeed spend more on costly gasoline and services during the month, this moderation in other price components underscores the nature of inflationary pressures.
Femasys (NASDAQ: FEMY ) stock is rocketing higher on Tuesday following approval from the Food and Drug Administration (FDA) for FemaSeed. FemaSeed is an infertility treatment that delivers sperm directly into a woman's fallopian tube.
Shares of biomedical firm Femasys (NASDAQ: FEMY ) more than doubled on Thursday. This followed an important intellectual property (IP) protection announcement.
After losing some value lately, a hammer chart pattern has been formed for Femasys Inc. (FEMY), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
What type of business is Femasys?
Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.
What sector is Femasys in?
Femasys is in the Healthcare sector
What industry is Femasys in?
Femasys is in the Medical Instruments & Supplies industry
What country is Femasys from?
Femasys is headquartered in United States
When did Femasys go public?
Femasys initial public offering (IPO) was on 18 June 2021
What is Femasys website?
https://www.femasys.com
Is Femasys in the S&P 500?
No, Femasys is not included in the S&P 500 index
Is Femasys in the NASDAQ 100?
No, Femasys is not included in the NASDAQ 100 index
Is Femasys in the Dow Jones?
No, Femasys is not included in the Dow Jones index
When does Femasys report earnings?
The next expected earnings date for Femasys is 09 August 2024